Qiagen N.V.

Equities

QGEN

NL0015002CX3

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			5-day change	1st Jan Change
45.22 ^USD	-0.48%		-3.81%	-1.27%

Dec. 11	Citigroup Downgrades QGEN to Neutral From Buy, Price Target is $55	MT
Dec. 03	Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM

Transcript : Qiagen N.V., Q3 2024 Earnings Call, Nov 07, 2024

Published on 11/07/2024 at 09:30 am EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, thank you for standing by. I am Katie, your call operator. Welcome, and thank you for joining QIAGEN's Q3 2024 Earnings

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Qiagen N.V.

Dec. 11	Citigroup Downgrades QGEN to Neutral From Buy, Price Target is $55	MT
Dec. 03	Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM
Dec. 02	Qiagen N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11:15 AM
Nov. 21	Qiagen N.V. - Special Call
Nov. 20	Oracle Corporation Names Stephen Rusckowski to the Board of Directors, Effective on November 18, 2025	CI
Nov. 20	Rebounds expected in Europe, focus on US reports	AN
Nov. 20	QIAGEN NV : Gets a Buy rating from Jefferies	ZD
Nov. 19	Qiagen N.V. Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 10:30 AM
Nov. 19	Diasorin and Qiagen, new test for the diagnosis of tuberculosis	AN
Nov. 18	Cellbxhealth, Qiagen Unit Enter Co-marketing Deal	MT
Nov. 17	Qiagen N.V. Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 12:40 PM
Nov. 17	Qiagen Seeks Acquisitions	CI
Nov. 11	QIAGEN NV : Deutsche Bank reiterates its Buy rating	ZD
Nov. 11	QIAGEN NV : DZ Bank reiterates its Buy rating	ZD
Nov. 11	QIAGEN NV : Buy rating from Berenberg	ZD
Nov. 10	QIAGEN N.V. Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025	CI
Nov. 05	Qiagen N.V., Q3 2025 Earnings Call, Nov 05, 2025
Nov. 05	Qiagen lifts adjusted EPS guidance after Q3 earnings beat and new acquisition
Nov. 05	Déjà Vu, With Better Balance Sheets
Nov. 05	QIAGEN NV : Deutsche Bank reiterates its Buy rating	ZD
Nov. 05	QIAGEN NV : UBS remains Neutral	ZD
Nov. 05	QIAGEN NV : Jefferies reiterates its Buy rating	ZD
Nov. 04	Qiagen N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 04	Qiagen N.V. Announces to Step Down of Thierry Bernard as CEO	CI
Nov. 04	Qiagen N.V. Reaffirms Earnings Guidance for the Fiscal Year 2025	CI